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Objectives 
Previously we have demonstrated that infants with CF from socio-economically disadvantaged areas 
in the UK have worse early outcomes than those from more affluent areas. In the present study, we 
used data from the UK CF Registry to examine the impact of newborn bloodspot screening (NBS) on 
clinical outcomes and health inequalities in children with CF born in the new millennium.  
Methods 
We obtained data on 4117 individuals with CF born between 2000 and 2014 who are captured in the 
UK CF Registry. Clinical outcomes were the trajectories of percent predicted FEV1 (ppFEV1) from age 
five, weight and body mass index (BMI) z-scores from age one, and time to chronic Pseudomonas 
Aeruginosa (PA) infection. We developed longitudinal models for ppFEV1, weight, and BMI and a 
time-to-event model for PA infection to assess the association of NBS with outcomes and potential 
interactions with childhood socio-economic conditions (SECs), measured by the index of multiple 
deprivation, whilst adjusting for sex, number of F508del copies, birth cohort, ethnicity, and 
pancreatic insufficiency. 
Results 
Complete data for the analysis of the effect on lung function, weight, BMI and time to chronic PA 
infection were available for 2267, 3424, 3410 and 3428 individuals, respectively. About one third of 
the individuals were diagnosed by NBS. NBS was associated with a shallower rate of lung function 
decline (0.45; 95%CI 0.13 to 0.76 per year), and higher average weight trajectory intercept (0.14; 
95%CI 0.06 to 0.23 standard deviations). We found no significant association of NBS with the 
intercept for lung function or BMI; or with longitudinal trajectories of weight and BMI. There was no 
significant interaction between NBS and childhood SECs. Evaluation of the PA outcome is ongoing. 
 
Conclusions 
Analysis of data from a large national CF Registry shows that NBS is associated with better lung 
function and increased weight for all children with CF, but it has not narrowed health inequalities.   
